WallStreetZenWallStreetZen

NASDAQ: AVBP
Arrivent Biopharma Inc Stock Ownership - Who owns Arrivent Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arrivent Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robin LachapelleCOO2026-10-3016,265$3.65
$59.37kBuy
Robin LachapelleCOO2026-10-30410$2.28
$935.21Buy
Robin LachapelleCOO2026-10-304,550$2.28
$10.38kBuy
Robin LachapelleCOO2026-10-301,820$2.28
$4.15kBuy
Robin LachapelleCOO2026-10-3017,648$6.24
$110.05kBuy
Hillhouse Investment Management Ltd10% Owner2025-12-10555,555$23.37
$12.98MSell

1 of 1

AVBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVBP insiders and whales buy or sell their stock.

AVBP Shareholders

What type of owners hold Arrivent Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hillhouse Investment Management Ltd7.97%3,929,117$53.59MInsider
James Healy3.44%1,696,752$23.14MInsider
Carl L. Gordon3.07%1,513,664$20.65MInsider
Orbimed Advisors LLC3.07%1,513,664$20.65MInsider
Robin Lachapelle1.96%965,383$13.17MInsider
Zhengbin Yao1.24%613,138$8.36MInsider
Stuart Lutzker0.30%147,744$2.02MInsider
James Paul Kastenmayer0.01%7,386$100.75kInsider
Suvret0.01%4,516$61.60kInstitution
Montanova Capital LLC0.01%4,515$61.58kInstitution

1 of 3

AVBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVBP0.09%21.07%Net SellingNet Buying
CADL0.07%22.78%Net BuyingNet Selling
FDMT0.11%22.42%Net SellingNet Selling
AURA0.09%4.39%Net Selling
WVE0.09%44.25%Net BuyingNet Selling
View Top Biotech Stocks

Arrivent Biopharma Stock Ownership FAQ

Who owns Arrivent Biopharma?

Arrivent Biopharma (NASDAQ: AVBP) is owned by 0.09% institutional shareholders, 21.07% Arrivent Biopharma insiders, and 78.84% retail investors. Hillhouse Investment Management Ltd is the largest individual Arrivent Biopharma shareholder, owning 3.93M shares representing 7.97% of the company. Hillhouse Investment Management Ltd's Arrivent Biopharma shares are currently valued at $53.59M.

If you're new to stock investing, here's how to buy Arrivent Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.